Clinico-pathological characteristics of patients cohort.

<p>Clinico-pathological characteristics of patients cohort.</p

Relationship between miRNAs expression and survival in glioma patients.

<p>A) Kaplan-Meier curves showing the relationship of miR-155, miR-21, miR-210 and miR-22 with Overall Survival in patients from the GBM dataset. B) Kaplan- Meier curves showing the relationship of miR-155, miR-1296, and miR-383 with Overall Survival in Grade III glioma patients from the LGG dataset.</p

Validation of microarray data by qRT PCR analysis.

<p>The 32 glioma samples and 4 NBT were analyzed by RT-qPCR for the expression of the 22 miRNAs identified by microarray profiling. Boxplots of miRNAs expression in normal brain tissues (NBT), WHO grade II gliomas (II) and WHO grade III and IV gliomas (III+IV). Expression levels are expressed as: target miRNA/RNU48 multiplied by 1000. The boxes mark the interquartile range, (interval between the 25th and 75th percentile). The lines inside the boxes denote median values, the symbol * denote the outliers. #NBT vs II vs III+IV comparison by Kruskall Wallis Test; §II vs III+IV comparison by Mann Whitney test.</p

Additional file 2: Table S2. of N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration

Primer sequences used for qRT-PCR, RACE, siRNAs, and vector construction in this study. (XLSX 11 kb